Pacira BioSciences
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Pacira BioSciences's past years’ income statements indicate that its last revenue has increased compared to the previous period by 1% to $674,978,000. The net income raised on $41,955,000 and profit margin reached 6%. Total operating expenses were $402,634,000.
Profit Margin
| 2014 | 197.66M | -13.71M | -6.94% |
|---|---|---|---|
| 2015 | 248.99M | 1.85M | 0.75% |
| 2016 | 276.37M | -37.94M | -13.73% |
| 2017 | 286.63M | -42.61M | -14.87% |
| 2018 | 337.27M | -471K | -0.14% |
| 2019 | 421.02M | -11.01M | -2.62% |
| 2020 | 420.83M | 145.52M | 34.58% |
| 2021 | 541.53M | 41.98M | 7.75% |
| 2022 | 666.82M | 15.90M | 2.39% |
| 2023 | 674.97M | 41.95M | 6.22% |
PCRX Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 674.97M | 666.82M | 541.53M | 420.83M | 421.02M | 337.27M | 286.63M | 276.37M | 248.99M | 197.66M |
Cost of revenue | 184.66M | 199.29M | 140.25M | 117.32M | 106.71M | 86.84M | 87.91M | 110.10M | 71.83M | 77.44M |
Gross profit | 490.30M | 467.52M | 401.27M | 303.50M | 314.31M | 250.43M | 198.71M | 166.26M | 177.16M | 120.22M |
Operating exp. | ||||||||||
Research and development | 76.25M | 84.79M | 55.54M | 59.42M | 72.11M | 55.68M | 57.29M | 45.67M | 28.66M | 18.73M |
Selling and marketing | 153.04M | 144.99M | 111.02M | 118.68M | 129.66M | 107.10M | 94.80M | 89.21M | 77.73M | 65.01M |
Total operating expenses | 402.63M | 396.60M | 268.44M | 260.80M | 278.60M | 232.95M | 218.78M | 198.29M | 167.70M | 125.39M |
Operating income | 87.67M | 60.02M | 131.06M | 46.35M | 38.11M | 15.91M | -24.93M | -32.02M | 9.45M | -5.16M |
Other income (expenses), net | -25.97M | -46.72M | -74.66M | -26.26M | -48.85M | -2.45M | -17.53M | -82K | -7.33M | -8.37M |
Income before tax | 61.70M | 13.30M | 56.40M | 20.08M | -10.74M | -425K | -42.47M | -37.84M | 2.12M | -13.54M |
Income tax expense | 19.74M | -2.60M | 14.42M | -125.43M | 268K | 46K | 140K | 105K | 264K | 173K |
Net income | 41.95M | 15.90M | 41.98M | 145.52M | -11.01M | -471K | -42.61M | -37.94M | 1.85M | -13.71M |
Earnings per share | ||||||||||
Basic EPS | 0.91 | 0.35 | 0.95 | 3.41 | -0.27 | -0.01 | -1.07 | -1.02 | 0.05 | -0.39 |
Diluted EPS | 0.81 | 0.34 | 0.92 | 3.33 | -0.27 | -0.01 | -1.07 | -1.02 | 0.04 | -0.39 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |